Patients with resected stage III colon cancer who were @ years of age or older , with an Eastern Cooperative Oncology Group performance status of @ or @ , from four randomised controlled trials ( NSABP C-@ , XELOXA , X-ACT , and AVANT ; @ patients in total ) were pooled and analysed .